Pharmacy benefits

The White House and HHS want to eliminate a “shadowy system of kickbacks” in the drug industry pipeline.

The administration’s proposal would be a boon for employers and employees — and bring actual drug costs into the light.

The administration’s proposal would be a boon for employers and employees — and bring actual drug costs into the light.

The Trump administration’s new prescription drug proposal is vital to correct an increasingly dysfunctional market for employer plan sponsors.

Under the proposal, safe-harbor protection would be allowed only for rebates on discounts offered directly to patients, and fixed-fee service arrangements between drugmakers and PBMs.

Walmart will leave CVS Health’s network that administers drug benefits for millions of Americans, in a dispute over costs that could roil the business of filling prescriptions.

Big pharma disruption and healthcare challenges and legislation are just a few of the big trends that will shape the benefits industry in 2019.

While it’s still early to tell what the acquisition will mean for healthcare, many experts are skeptical it will drive down costs for employers or employees.

Healthcare quality, literacy and employee engagement are key concerns for employers, said experts at the National Alliance of Healthcare Purchaser Coalitions' annual forum.

Healthcare quality, literacy and employee engagement are key concerns for employers, said experts at the National Alliance of Healthcare Purchaser Coalitions' annual forum.